ZIOPHARM Reports Second-Quarter 2015 Financial Results and Recent Activities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
Go back to ZIOPHARM Reports Second-Quarter 2015 Financial Results and Recent Activities
August 11, 2015 7:55 AM EDT
JPMorgan downgraded Intrexon (NYSE: XON) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Intrexon click here. For more ratings news on Intrexon click here.
Shares of Intrexon closed at $57.68 yesterday.
...
More
August 11, 2015 6:47 AM EDT
Mizuho Securities downgraded Intrexon (NYSE: XON) from Neutral to Underperform with a price target of $45.00.
Analyst Peter Lawson commented, "We are downgrading XON from Neutral to Underperform. The stock is over 20% above our $45 PT, and while pipelines of collaborators are progressing, we need... More
August 10, 2015 5:21 PM EDT
Intrexon (NYSE: XON) reported Q2 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $44.9 million versus the consensus estimate of $55.52 million.
For earnings history and earnings-related data on Intrexon (XON) click here.
...
More
